Molecular imaging of isolated peptidoglycans as novel platform for antibiotic development

Because of the ever increasing resistances of pathogenic bacteria, the development of novel antibiotic entities is urgently needed today. Ever since, the peculiar procaryotic cell wall synthesis has been considered a specifically promising target for the development of antiinfective therapeutics. In order to facilitate the identification of novel antibiotic leads targeting cell wall synthesis, our group is studying the molecular composition of isolated peptidoglycans from different pathogenic bacteria prior and after antibiotic treatment.

Molecular imaging of the antibiotic-impaired ultrastructural murein morphology will prospectively not only allow the identification of novel antibiotic leads but also enable valuable insights into the mechanisms of action concerning cell wall synthesis.

Molecular imaging of a native isolated Escherichia coli peptidoglycan sacculus. Note the nanoscale resolution of single glycan chains, allowing the interpretation of murein network morphology on a molecular scale. (white and blue arrows mark peptidoglycan strands).

Molecular imaging of ampicillin-treated isolated Escherichia coli peptidoglycan sacculus. Note the nanoscale resolution of single structurally impaired peptidoglycanglycan strands, allowing the depiction of affected peptidoglycan morphology after ampicillin treatment (white arrow = altered peptidoglycan strand evoked by ampicillin treatment).

Natural products´ mechanisms of action

Although modern medicinal chemistry has achieved striking advances in the past, the plethora of new anti-infective and anti-cancer agents are still initially identified in a plant, animal or microorganism.

The subsequent elucidation of the mechanisms of action of such bioactive natural products (NPs) is yet still an essential but tedious process, hindered by a number of shortcomings.

In order to identify a target structure in an alternative way, our group is using ultrastructural morphological assessments of cells, tissues and whole organisms as a shortcut to pinpoint potential mechanisms of action of a bioactive NP. This information can subsequently allow the more detailed description of a possible mechanism of action as well as of protein targets affected by the investigated NP.

(Ultra)-structural elucidation by microscopic techniques

The assessment of relevant structural alterations in our group is performed by a variety of microscopic techniques. On the one hand, classical light microscopic approaches (brightfield, darkground, phase contrast, polarization, fluorescence as well as DIC) are represented in our lab, allowing the examination of biological material on the lower micrometer scale (lateral resolution down to 0.2 µm).

On the other hand, innovative investigations on a nanometer scale are also possible by four atomic force microscopes (AFMs) in our lab, allowing lateral resolutions down to a fraction of an ångström (typically down to roughly 5 nm in biological material and under ambient conditions).

As a topographical technique, gaining insight into internal features of biological material by atomic force microscopy is still a challenging process. We therefore established an ultra-microtomic protocol, allowing insight into internal features of virtually any cell, tissue and organism by AFM for the first time. This technique was used in the recent years to describe the mechanism of action of different bioactive natural products.

Developed workflow for the facile ultrastructural elucidation of internal features of organisms, tissues or single cells by Atomic Force Microscopy (Herrmann et al., J. Struc. Biol. 2019)

AFM-elucidated ultrastructure of C. elegans L4 hermaphrodite´s spermathecal tissues after treatment with the quassinoid ailanthone (C, 50 µM) and compared to untreated morphology (A). S = single spermatocyte, Sp = single spermatid. (Adapted from Knetzger et al., Doi:10.3390/molecules26237354)

In silico and enzymatic techniques

Additionally, our group is also focused on enzymatic as well as in silico techniques. After the identification and structural elucidation of a target protein, in silico techniques can be applied to screen large substance databases for compounds potentially interacting with the protein of interest (virtual screening). Furthermore, molecular docking analyses subsequently allow the estimation of the possible interaction of a set of given compounds with a protein, enabling us to identify the most promising hits for in vitro testing.

Spectroscopy-based in vitro inhibition experiments employing the recombinantly produced target protein are afterwards applied in order to verify the in silico predictions as well as to gain further insight into the mechanism of action of an enzyme inhibitor.

Available methods in the Herrman lab

Atomic Force Microscopy (altogether 4 Bio-AFMs available)

Sample preparation by ultra-microtomy

Light microscopy (epifluorescence, phase contrast, DIC...)

In silico drug design (pharmacophore elucidation, virtual screening, molecular docking)

Recombinant expression of target proteins

Assessment of enzyme kinetics

Current research projects

AFM-based molecular analysis of isolated peptidoglycan sacculi to establish a screening assay for novel cell wall inhibiting antibiotics

Ultrastructural evaluation of the antibacterial effects of galectins 3 and 4 against E. coli (cooperation with USP Sao Paulo, Prof. Dr. Baruffi)

Ultrastructural evaluation of the mechanism of action of different quassinoids and proanthocyanidins against Caenorhabditis elegans

Ultrastructural evaluation of anthelmintic effects exerted on Caenorhabditis elegans by treatment with a proanthocyanidin-rich extract from Combretum mucronatum

Development of ultramicrotomy-based techniques allowing the ultrastructural characterization of cells, tissues and organisms by AFM and light microscopy

Supervised PhD theses

Daniel Amiteye, "In silico identification and AFM-based ultrastructural evaluation of natural products as inhibitors of the bacterial cell wall synthesis", since 2021

Supervised master theses

Niklas Mayer, 2024
Mirko Hirsch, 2023
Leonardo Elsbroek, "Ultrastructural characterization of isolated peptidoglycan sacculi by atomic force microscopy", 2021/22
Nicola Knetzger, "Elucidating the mechanism of action of two quassinoids against Caenorhabditis elegans by Atomic Force Microscopy (AFM)", 2020
Daniel Dornbusch, "Entwicklung einer rasterkraftmikroskopischen Methode zur Visualisierung morphologischer Veränderungen an Leishmanien nach Behandlung mit Tubulin-modifizierenden Wirkstoffen", 2019
Katharina Possart, "Rationale Suche nach Naturstoffen mit antitrypanosomaler Aktivität", 2019
Nirina Sivakumar, "Naturstoffe mit Hemmwirkung auf die Pteridinreduktase 1 von Leishmania major und Trypanosoma brucei", 2016
Alexandra Heithorst, "Mechanistische Untersuchungen zur Hemmung trypanosomaler Enzyme durch ausgewählte Naturstoffe", 2016